Literature DB >> 2832476

Identification of platelet-activating factor receptors in P388D1 murine macrophages.

F H Valone1.   

Abstract

Platelet-activating factor (PAF) binding and metabolism by eight murine and human cell lines was analyzed. Only the murine P388D1 macrophage line had specific, high affinity PAF binding sites. PAF binding reached saturation within 10 min at room temperature and was irreversible. Minimal PAF metabolism was observed at the time binding saturation was achieved. Scatchard analysis of PAF binding revealed a single class of PAF receptors (7872 +/- 1310/cell) which had a dissociation constant of 0.08 +/- 0.01 nM (mean +/- SEM, eta = 6). The dissociation constant was confirmed independently by quantifying the kinetics of initial specific PAF binding. PAF binding was stereospecific, required an sn-2 acetyl substituent, and was inhibited by structurally diverse PAF antagonists including kadsurenone, BN 52021, triazolam, and CV3988. The fact that the receptors are functionally active was shown by the observation that 1 to 100 pM PAF increased free intracellular calcium in P388D1 cells in a dose-related manner. These studies demonstrate that P388D1 macrophages have functional PAF receptors whose affinity and structural specificities are similar to PAF receptors in other cells. The availability of a stable cell line that binds but does not metabolize PAF will greatly facilitate studies of the PAF receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832476

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.

Authors:  M J Parnham; C Bittner; G Lambrecht
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

Review 2.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  Effect of platelet-activating factor on secretion of mucous glycoprotein from chinchilla middle ear epithelial cells in vitro.

Authors:  J Lin; Y Kim; C Lees; S K Juhn
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.

Authors:  N M Ruis; J K Rose; F H Valone
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 5.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.

Authors:  P E Poubelle; D Gingras; C Demers; C Dubois; D Harbour; J Grassi; M Rola-Pleszczynski
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

7.  A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages.

Authors:  S Ishii; Y Matsuda; M Nakamura; I Waga; K Kume; T Izumi; T Shimizu
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

8.  Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor.

Authors:  F H Valone; N M Ruis
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

9.  Metabolism of platelet-activating factor in human haematopoietic cell lines. Differences between myeloid and lymphoid cells.

Authors:  M C Garcia; C Garcia; M A Gijon; S Fernandez-Gallardo; F Mollinedo; M Sanchez Crespo
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

10.  Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.

Authors:  C M Lee; L M Jiang; H S Shang; P M Hon; Y He; H N Wong
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.